Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 765 of 1,261
  1. US 8969296

    TGFP-CAP peptide and its uses

    CAREGEN CO., LTD. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  2. US 8969077

    Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord

    The Regents of the University of California · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  3. US 8968996

    Compositions and methods for rapid immunization against dengue virus

    Takeda Vaccines, Inc. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  4. US 8968785

    Surgical compositions

    Covidien LP · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  5. US 8968783

    Hydrogel implants with varying degrees of crosslinking

    Covidien LP · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  6. US 8968756

    Fabrication of biscrolled fiber using carbon nanotube sheet

    The Board of Regents of the University of Texas System · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  7. US 8968703

    13C-MR detection using hyperpolarised 13C-fructose

    The Regents of the University of California · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  8. US 8968699

    Switchable nano-vehicle delivery systems, and methods for making and using them

    The Regents of the University of California · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  9. US 8968234

    Method of using vasoconstrictive agents during energy-based tissue therapy

    Covidien LP · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  10. US 8968719

    Live, oral vaccine for protection against Shigella dysenteriae serotype 1

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  11. US 8969382

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  12. US 8968729

    Date pit composition for the treatment of animals

    UNITED ARAB EMIRATES UNIVERSITY · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  13. US 8968736

    Human antibodies to GFRα3 and methods of use thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  14. US 8969287

    Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry

    The Regents of the University of California · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  15. US 8969356

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  16. US 8969359

    Gyrase and topoisomerase IV inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  17. US 8969372

    Aryl imidazoles and their use as anti-cancer agents

    Aptose Boisciences Inc. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  18. US 8969409

    Treatment for pulmonary hypertension

    United Therapeutics Corporation · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  19. US 8969574

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  20. US 8969653

    Extracellular vesicles derived from gram-positive bacteria, and use thereof

    Aeon Medix Inc. · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted
  21. US 2015057294

    1H-INDAZOLE-3-CARBOXAMIDE COMPOUNDS AS GLYCOGEN SYNTHASE KINASE 3 BETA INHIBITORS

    ACRAF [IT] · Granted Feb 26, 2015 · Expires Feb 21, 2035

    granted
  22. US 8962580

    Chemical modifications of monomers and oligonucleotides with cycloaddition

    Alnylam Pharmaceuticals, Inc. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  23. US 8962637

    Bicyclic compounds and their uses as dual c-SRC/JAK inhibitors

    Aurigene Discovery Technologies Limited · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted
  24. US 8962653

    Quinolinone-carboxamide compounds as 5-HT4 receptor agonists

    Theravance Biopharma R&D IP, LLC · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.